New York, USA – February 22, 2024 – Complement therapeutics and iPSC-derived therapies offer promising avenues for clinical applications across a broad spectrum of diseases. With a steadfast dedication to fostering global health, Creative Biolabs offers a suite of cutting-edge solutions and products to propel the discovery and advancement of effective therapies.
“Dysregulation of complement activation can instigate and exacerbate numerous inflammatory diseases. Particularly, abnormalities in the function or regulation of the complement membrane attack complex (MAC) can have profound implications, leading to a range of diseases, from rare genetic disorders and more prevalent chronic inflammatory ailments,” shared a scientist at Creative Biolabs. “This is primarily due to the MAC’s detrimental role in host cell destruction and activation of inflammation.”
Creative Biolabs delivers a comprehensive array of therapeutic antibodies, inhibitors, and complement convertases such as C3 convertase, alongside tailored services based on the MAC to bolster the development of complement therapeutics and novel drugs, including:
* Complement therapeutic target-C6
* Complement therapeutic target-C7
* Complement therapeutic target-C8
* Complement therapeutic target-C9
For iPSC-derived therapy research, Creative Biolabs has assembled a team of highly skilled experts from diverse backgrounds relevant to cell therapy research and development, offering custom services and products to expedite the progress of global clients’ programs.
“CRISPR/Cas9 is a simple and efficient genome editing tool for stem cells that has been widely used in basic and medical research. Previously, we have employed CRISPR/Cas9 technology to generate innovative and potent cell therapy solutions for our customers,” the scientist remarked.
Backed by well-established platforms and experienced scientists, the company provides a wide range of products and services about CRISPR Cas9 stem cells and custom iPSC-derived services.
CRISPR Cas9 stem cells offerings include:
* gRNA Design and vector construction service
* CRISPR/Cas9 cell line engineering
* CRISPR/Cas9 genome knockout kits
* Transgenic mice with CRISPR/Cas9-mediated genome modifications
Highlighted custom iPSC-derived services encompass:
* iPSC reprogramming services
* iPSC culture service
* Characterization services of iPSC pluripotency
* iPSC genome editing service
* iPSC differentiation service
For further details regarding Creative Biolabs and its custom solutions for disease therapy research, please visit https://www.creative-biolabs.com/complement-therapeutics.
About Creative Biolabs
Creative Biolabs stands as a premier biotechnology company dedicated to advancing scientific research and drug development. Focusing on various disease therapy advancements, the company delivers comprehensive and innovative solutions to propel ongoing research endeavors. Collaborating with researchers worldwide, Creative Biolabs’ team of experts addresses the most formidable challenges in biomedical research.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-830-6441Country: United StatesWebsite: https://www.creative-biolabs.com/complement-therapeutics
